Robert C. Steyert

FDA investigator

Appears on 6 documents from 2006 to 2016, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).

6
Documents on file
6.7
Observations per 483
2006
First seen
2016
Most recent

What they cite most

From 39 observations

Activity by year

2006: 1, 2013: 1, 2014: 1, 2015: 1, 2016: 2

Where

New York 5 · Florida 1

Is Robert C. Steyert coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Hi-Tech Pharmacal, an AKORN CompanyJul 15, 2016 · Amityville, New York
483 Region Care Inc. (Northwell Health)Jun 10, 2016 · Great Neck, New York
483 Hi-Tech Pharmacal, an AKORN CompanyJul 20, 2015 · Amityville, New York
483 Sina LLC, dba OncoMed (Onco 360)Aug 22, 2014 · Great Neck, New York
483 AnazaoHealth CorporationFeb 22, 2013 · Tampa, Florida
483 Region Care, Inc.,Apr 5, 2006 · Great Neck, New York

About this profile

What does Robert C. Steyert inspect?

Robert C. Steyert appears on 6 documents on file covering 3 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Robert C. Steyert is dated Jul 15, 2016.

FDA Investigator Robert C. Steyert: 483s & Inspections · FDA Intel